DNA increases non-specific DNA and RNA polymerase activity and results in premature DNA polymerase arrest, which is Chromium (Cr) is a human carcinogen and a potent DNA thought to result from the production of 'Cr-mediated' damaging agent. Incubation of DNA with CrCl 3 resulted interstrand crosslinks (10) . Hence, the genotoxic activity of in dose-dependent binding of Cr to DNA and, at conCr likely results from: (i) the production of reactive oxygen centrations Ͼ20 µM, altered the electrophoretic mobility species accompanying the reduction of Cr(VI) to Cr(V), Cr(IV) of a 100 bp oligonucleotide. We also demonstrate that high and Cr(III) species; (ii) the direct binding of Cr(III) and mobility group (HMG) proteins 1 and 2 bind Cr-damaged possibly Cr(V) to DNA.
DNA (Cr-DNA). Protein binding was lesion density-depend-
The high mobility group (HMG) proteins are a family of ent, with maximal binding to DNA treated with 100 µM low molecular weight chromatin proteins which are widespread CrCl 3 . HMG2 binds to Cr-DNA with a calculated K d of and highly conserved in eukaryotic organisms (11) . While thẽ10 Ϫ9 M. These proteins also bound DNA obtained from functions of these proteins have not been fully elucidated, they chromate-treated cells. These results suggest that the covaare believed to play an important role in chromatin structure/ lent attachment of Cr to DNA induces alterations in DNA function and affect the binding of H1 histone to DNA (11) . structure which are recognized by HMG1 and HMG2.
HMG1 and HMG2 are structurally similar and members of Therefore, these proteins may function as Cr-damaged the HMG box family of proteins. HMG boxes are DNA DNA recognition proteins in vivo and as a consequence of binding domains containing~80 amino acids which have been binding, may play a role in directing the cellular response identified in a large number of proteins involved in the control to Cr-DNA adduct formation.
of gene expression (reviewed in 12). A characteristic feature of all HMG box proteins is their ability to recognize bent DNA structures (12) . Previous work has demonstrated that Introduction HMG1, HMG2 and other HMG box-containing proteins recogChromium is a well established human carcinogen (1) .
nize DNA modified by the cancer chemotherapy drug cisplatin Individuals with occupational exposure to specific salts of (13, 14) . However, the ability of these proteins to recognize chromium and other metals are at an increased risk of develop-DNA damaged by other agents has not been extensively ing lung, nasal and skin cancer (1) . Chromium has been shown examined. In the current study, we have investigated the to be carcinogenic in animal models and also has carcinogenic interaction of HMG proteins with chromium-damaged DNA and mutagenic activity in vitro mammalian cell assay systems (Cr-DNA). Our results demonstrate that these proteins bind (2) (3) (4) (5) (6) . A large body of work has also demonstrated that Cr-DNA, suggesting that they are involved in the recognition chromium is genotoxic and a potent DNA damaging agent. Cr(VI) to Cr(V) and Cr(III) species by enzymatic and nontotal volume of 10 ml overnight. The DNA-cellulose was washed twice in distilled water, twice in 20 mM Tris, pH 6.8, 500 mM NaCl, 10% glycerol, 0.1% NP-40, 0.5 mM dithiothreitol (DTT) and finally in 10 mM Tris, pH 7.5, *Abbreviations: SCE, sister chromatid exchange; HMG, high mobility group; Cr-DNA, chromium-damaged DNA; PMSF, phenylmethylsulfonyl fluoride; and stored at 4°C. The Cr-DNA preparation is stable for at least 1 week. The amount of Cr bound to DNA was determined by inductively coupled plasma/ DTT, dithiothreitol; PBS, phosphate-buffered saline; TBS, Tris-buffered saline; BSA, bovine serum albumin; HRP, horseradish peroxidase; OPD Omass spectrometry analysis (15) . To prepare Cr-damaged cellular DNA, 5ϫ10 7 HL60 cells were placed in phenylenediamine dihydrochloride; DAB, 3,3Ј-diaminobenzidine tetrahydrochloride.
100 mm dishes containing 20 ml RPMI 1640 medium supplemented with 5% fetal bovine serum and subsequently treated with 0, 10 or 100 µM potassium chromate for 3 h. After treatment, the cells were pelleted by centrifugation, resuspended in 5 ml 25 mM Tris, pH 7.5, 25 mM EDTA, 100 mM NaCl. The cells were lysed by addition of SDS (final concentration 0.5%) and incubated with proteinase K (10 µg/ml) for 2 h on a rocker platform. Samples were extracted with phenol/chloroform and the DNA was precipitated by the addition of 2 vol ethanol.
Preparation of labeled DNA
A 100 bp fragment containing the multiple cloning region and 50 bp of 5Ј flanking region of pUC18 was amplified by PCR and cloned into a TA cloning vector. For preparation of probe, plasmid DNA was digested with EcoRI, end-filled with [α-32 P]dATP at the 5Ј overhang using Klenow fragment, run on a 1% agarose gel and subsequently purified from the gel using a GenElute agarose spin column (Supelco, Bellefonte, PA). Five nanograms of the labeled fragment were incubated with CrCl 3 and subsequently spun through a Sephadex G50 spin column to remove unbound Cr. The DNA samples were run on 5% polyacrylamide gels, using a high ionic strength buffer system (50 mM TrisϪHCl, pH 8.5, 0.38 M glycine and 1 mM EDTA), the gels dried and autoradiographed (16) .
HMG protein purification and preparation of antiserum
Calf thymus tissue was obtained from a local slaughter house and immediately frozen in liquid nitrogen. HMG proteins were purified from calf thymus by perchloric acid extraction, acetone precipitation and ion exchange chromatography as described (17) . Polyclonal antiserum to HMG1 was prepared in chickens using purified protein as antigen and purified by affinity chromatography (18, 19) . 
Results

Damaged DNA binding assay
The first series of experiments were designed to assess Cr Protein samples (purified protein and tissue extracts) were mixed with binding to DNA. Sheared DNA was incubated with increasundamaged DNAϪ and Cr-DNAϪcellulose and incubated (17 h at 4°C) on ing concentrations of CrCl 3 , after which the samples were a rotating platform, positioned 60°from the horizontal axis, and subsequently extensively dialyzed to remove unbound Cr and subsequently centrifuged (3000 g for 2 min). The pellets were washed three times with 3 ml wash buffer (10 mM Tris, pH 7.5, 1 mM EDTA, 0.5 mM DTT, 10%
analyzed by inductively coupled plasma/mass spectrometry. polyacrylamide gel. DNA treated with higher Cr concentrations Protein binding was also assessed using a solid phase binding protocol.
had decreased mobility in the gel (Figure 2) . The Cr-induced DNA was isolated from cells which were untreated or treated with K 2 CrO 4 , changes in electrophoretic mobility of DNA suggest a change as described above. The DNA was sheared by repeated passage through a in DNA structure, which may result from the production of 21 gauge needle and applied to a polylysine-coated 96-well microtiter plate Cr-induced DNA crosslinks. when DNA was modified with 100 µM CrCl 3 ( Figure 4 ).
Western immunoblots
Under the conditions of the assay, HMG proteins bound CrProtein samples were run on 12.5% SDSϪpolyacrylamide gels and DNA with a minimum lesion density of~10 Cr adducts/10 3 transferred to a nitrocellulose membrane. The membrane was blocked in TBS nucleotides as determined by inductively coupled plasma/mass blocking solution (TBS containing 5% powdered milk and 1% BSA) for spectrometry analysis.
30 min and then incubated with anti-HMG antibody (diluted 1:1000 in TBS, 1% BSA) at 4°C overnight (19) . The membrane was washed and incubated
The goal of the next experiments was to assess protein with HRP-conjugated rabbit anti-chicken IgG (diluted 1:1000 in TBS conaffinity for Cr-DNA. Increasing concentrations of HMG2 were taining 20 µl/ml normal rabbit serum) for 30 min at room temperature.
incubated with a fixed amount of Cr-DNA, the samples Bound antibody was detected using 3,3Ј-diaminobenzidine tetrahydrochloride were washed and bound proteins were eluted and run on (DAB) as substrate. Stock solutions of DAB were prepared at a concentration of 0.5 mg/ml in TBS, 0.02% H 2 O 2 being added prior to use.
SDSϪpolyacrylamide gels. The amount of protein bound was assessed by scanning the gels in a densitometer. Analysis of the binding data on Scatchard plots (21) indicated that HMG2 binds Cr-DNA with a K d of~10 Ϫ9 M ( Figure 5) .
The previous studies revealed that purified HMG1 and HMG2 will selectively bind Cr-DNA. We also determined whether these proteins are functionally active Cr-DNA binding SDSϪpolyacrylamide gels. HMG protein binding was deter- Cr-DNA adducts formed in cells exposed to Cr. For these experiments, HL60 cells were incubated in the absence or presence of K 2 CrO 4 (mammalian cells are unable to take up cisplatin-modified DNA and upon binding, induce additional CrCl 3 ; 7 and 8). After incubation, the cells were washed and bending. DNA was isolated and used as substrate in a solid phase DNA binding assay. We observed increased HMG protein binding Our results suggest that Cr(III) binding to DNA produces to DNA obtained from cells treated with chromate ( Figure 7 ). distortions in DNA structure which are recognized by HMG1 These results provide direct evidence that HMG proteins are and HMG2. Cr alters DNA structure, which may result from capable of recognizing Cr-DNA adducts arising in chromatethe production of Cr-induced interstrand crosslinks (which can treated cells. In addition, we find that HMG proteins obtained be visualized in Figure 1 ). Relevant to this point are findings from chromate-treated cells are functionally active as Cr-DNA that Cr bound to DNA alters non-specific DNA and RNA binding proteins (data not shown).
polymerase activity and results in premature DNA polymerase arrest (10) . These effects are likely the result of Cr adduct Discussion formation and/or resulting changes in DNA structure. The ability of HMG proteins to bind Cr-DNA suggests that Cr Cr(III) is a well-established DNA damaging agent. Incubation binding produces structural alterations in DNA which are of DNA with CrCl 3 resulted in dose-dependent binding of Cr.
similar to those obtained with cisplatin. Although HMG In addition, at concentrations Ͼ20 µM CrCl 3 , altered mobility proteins bind tightly to Cr-DNA (HMGϪCr-DNA complexes of a 100 bp DNA fragment was observed in a gel mobility are stable in 0.5 M NaCl) the affinity of HMG2 for Cr-DNA shift assay. In the course of this work, we also found that (K d~1 0 Ϫ9 M) is~10-fold less than for cisplatin-modified DNA HMG1 and HMG2 bind to Cr-DNA. Protein binding was both (K d~1 0 Ϫ10 M; 17). Cr lesion and time dependent. HMGϪCr-DNA complexes are Our studies, using whole tissue extracts as input protein for stable in Ͼ0.5 M NaCl and HMG2 binds Cr-DNA with a K d binding assays, indicate that the ability of HMG proteins to of~10 Ϫ9 M.
selectively recognize Cr-DNA is not just an in vitro finding. HMG1, HMG2 and other HMG box proteins specifically
Further, these problems also recognize Cr-DNA lesions formed recognize bent DNA structures (12) , which is probably a under normal physiological conditions, as they bound DNA reflection of their normal in vivo function. For example, they isolated from chromate-treated cells. Taken together, these bind cruciform and four-way junction DNA and have also findings suggest that HMG proteins are also functionally active been shown to bind cisplatin-modified DNA (12, 13) . Cisplatin damage recognition proteins in vivo. In addition to recognition, is known to form well-characterized intrastrand crosslinks HMG1 and HMG2 may also be involved in guiding the cellular between adjacent purines in genomic DNA. The resulting response following the formation of Cr adducts in DNA. For adducts induce a bend of 32-34°towards the major groove (23) (24) (25) . HMG proteins dock in the widened minor groove of example, these proteins could be involved in the repair of
